Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q2 2023 call → NOWe need to determine if management conveys that the business is currently outgrowing the company's own size, with a disproportion between the company's smallness and the scale of what is arriving now. The transcript: Perion Network, Q2 2023. Revenue $178.5M, growth 22%. They talk about outperforming industry, EBITDA growth 45%. They discuss Retail Media, CTV, SORT, etc. They mention "we continue to outperform the industry" and "gaining market share". They talk about growth in various segments. But do they convey that the company is small relative to what is happening? They don't explicitly say "we are small" or "this is disproportionately large". They talk about growth rates, but that's typical. They mention "our ability to capture shift in advertising budgets" etc. They don't describe a single customer or contract that rivals the company. They don't say "we are handling volumes out of reach for a company of our size". They do mention "we are raising guidance" and "strong results". But the question is about a disproportion between size and what's arriving. The company is a mid-cap ad tech with $178M quarterly revenue, not tiny. They are a leading participant? They say "outperform the industry" but that's not necessarily a disproportion. They don't convey that the current activity is disproportionately large relative to their smallness. They talk about growth but not in a way that suggests they are small and overwhelmed by demand. They mention "we have a great belief in Microsoft Advertising" etc. No explicit contrast. So answer NO. Check if any statement implies: "we are small and this is big" - not really. They talk about "our strong results" and "we continue to grow" but no disproportion. They mention "we are constantly looking to add more publishers" but that's normal. They don't say "this single customer could rival our revenue" etc. So NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.